Comments on "High efficacy of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in Black adults in the United States, including those with pre-existing HIV resistance and suboptimal adherence".
作者信息
Alidjinou Enagnon Kazali
机构信息
Laboratoire de Virologie, Univ Lille, CHU de Lille, Lille, France.
出版信息
J Med Virol. 2024 Oct;96(10):e29950. doi: 10.1002/jmv.29950.
PMID:39350643
Abstract
摘要
Zotero 插件